A non-neutralizing antibody broadly protects against influenza virus infection by engaging effector cells.
Hemagglutinin (HA) is the immunodominant protein of the influenza virus. We previously showed that mice injected with a monoglycosylated influenza A HA (HAmg) produced cross-strain-reactive antibodies and were better protected than mice injected with a fully glycosylated HA (HAfg) during lethal dose...
Guardado en:
Autores principales: | Yi-An Ko, Yueh-Hsiang Yu, Yen-Fei Wu, Yung-Chieh Tseng, Chia-Lin Chen, King-Siang Goh, Hsin-Yu Liao, Ting-Hua Chen, Ting-Jen Rachel Cheng, An-Suei Yang, Chi-Huey Wong, Che Ma, Kuo-I Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1d68c84373464a6bb70bde385675c643 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural basis of glycan276-dependent recognition by HIV-1 broadly neutralizing antibodies
por: Christopher A. Cottrell, et al.
Publicado: (2021) -
Maternal Broadly Neutralizing Antibodies Can Select for Neutralization-Resistant, Infant-Transmitted/Founder HIV Variants
por: David R. Martinez, et al.
Publicado: (2020) -
The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies.
por: Devin Sok, et al.
Publicado: (2013) -
Computational prediction of broadly neutralizing HIV-1 antibody epitopes from neutralization activity data.
por: Andrew L Ferguson, et al.
Publicado: (2013) -
Elimination of HIV-1-infected cells by broadly neutralizing antibodies
por: Timothée Bruel, et al.
Publicado: (2016)